Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD)
Research facility
Location:
Frankfurt am Main,
Germany (DE)
Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposing (2025)
Haupt J, Keminer O, Neser C, Windshügel B, Wiltzsch V, Schmidt JR, Pliushcheuskaya P, et al.
Journal article
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis (2023)
Fitzgerald O, Behrens F, Barton A, Bertheusen H, Boutouyrie-Dumont B, Coates L, Davies O, et al.
Journal article, Review article
Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021)
Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al.
Conference contribution